Jan A Roth1, Sarah Tschudin-Sutter2, Marc Dangel2, Reno Frei3, Manuel Battegay2, Andreas F Widmer2. 1. Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Switzerland; University of Basel, Switzerland; Department of Internal Medicine, University Hospital Basel, Switzerland. 2. Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Switzerland; University of Basel, Switzerland. 3. University of Basel, Switzerland; Division of Clinical Microbiology, University Hospital Basel, Switzerland.
Abstract
BACKGROUND AND AIMS: The widely used Pitt Bacteraemia Score (PBS) has repeatedly been described as a risk factor for short-term mortality in Staphylococcus aureus bloodstream infection (BSI), but little is known about its overall predictive performance. We therefore aimed to externally validate the PBS in S. aureus BSIs. METHODS: We performed a retrospective validation study at the University Hospital Basel. Adult patients with a first episode of methicillin-susceptible S. aureus BSI between January 2008 and December 2013 were eligible for the study. We measured the overall discriminative power of the PBS at day of BSI onset in predicting 30-day all-cause mortality by receiver-operating characteristics analysis. For each PBS cut-off, we calculated the corresponding sensitivity, specificity and predictive values for prediction of 30-day all-cause mortality. RESULTS: A total of 329 patients were included in the final analysis: The median PBS at BSI onset was 0 (interquartile range, 0-2) with patients suffering from various comorbidities (Charlson Comorbidity Index median 3, interquartile range 1-5). Thirteen percent of patients (43/329) died within 30 days from any cause. At BSI onset, 52% (170/329) of patients had a PBS of zero; the concomitant specificity and positive predictive value for prediction of 30-day all-cause mortality were 0% and 13%, respectively. The overall performance of the PBS in predicting the 30-day all-cause mortality was lower than published, with an area under the curve of 0.711 (95% confidence interval 0.614-0.807; p <0.001). CONCLUSIONS: For short-term mortality, the PBS had a low predictive value in a patient population with methicillin-susceptible S. aureus BSI. There is a need to improve simple clinical scores to better predict mortality, in particular for S. aureus.
BACKGROUND AND AIMS: The widely used Pitt Bacteraemia Score (PBS) has repeatedly been described as a risk factor for short-term mortality in Staphylococcus aureus bloodstream infection (BSI), but little is known about its overall predictive performance. We therefore aimed to externally validate the PBS in S. aureus BSIs. METHODS: We performed a retrospective validation study at the University Hospital Basel. Adult patients with a first episode of methicillin-susceptible S. aureus BSI between January 2008 and December 2013 were eligible for the study. We measured the overall discriminative power of the PBS at day of BSI onset in predicting 30-day all-cause mortality by receiver-operating characteristics analysis. For each PBS cut-off, we calculated the corresponding sensitivity, specificity and predictive values for prediction of 30-day all-cause mortality. RESULTS: A total of 329 patients were included in the final analysis: The median PBS at BSI onset was 0 (interquartile range, 0-2) with patients suffering from various comorbidities (Charlson Comorbidity Index median 3, interquartile range 1-5). Thirteen percent of patients (43/329) died within 30 days from any cause. At BSI onset, 52% (170/329) of patients had a PBS of zero; the concomitant specificity and positive predictive value for prediction of 30-day all-cause mortality were 0% and 13%, respectively. The overall performance of the PBS in predicting the 30-day all-cause mortality was lower than published, with an area under the curve of 0.711 (95% confidence interval 0.614-0.807; p <0.001). CONCLUSIONS: For short-term mortality, the PBS had a low predictive value in a patient population with methicillin-susceptible S. aureus BSI. There is a need to improve simple clinical scores to better predict mortality, in particular for S. aureus.
Authors: Amy Legg; Niamh Meagher; Sandra A Johnson; Matthew A Roberts; Alan Cass; Marc H Scheetz; Jane Davies; Jason A Roberts; Joshua S Davis; Steven Y C Tong Journal: Clin Drug Investig Date: 2022-10-10 Impact factor: 3.580
Authors: Emily M Eichenberger; Felicia Ruffin; Batu Sharma-Kuinkel; Michael Dagher; Lawrence Park; Celia Kohler; Matthew R Sinclair; Stacey A Maskarinec; Vance G Fowler Journal: Transpl Infect Dis Date: 2021-12-16 Impact factor: 2.228
Authors: Thomas P Lodise; Ariel Berger; Arman Altincatal; Rosa Wang; Tarun Bhagnani; Patrick Gillard; Nicole G Bonine Journal: Open Forum Infect Dis Date: 2019-04-23 Impact factor: 3.835